Tenaya Therapeutics, Inc. financial statements
Tenaya Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 90.6M | 10-K |
| Cash and equivalents | USD 100.55M | 10-Q |
| Total debt | USD 10.83M | EODHD |
Tenaya Therapeutics, Inc. financials on 6ix · Tenaya Therapeutics, Inc. on 6ix